Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients
Recruitment status was: Recruiting
18F-FDG PET, a whole-body imaging technology based on glucose metabolism, can effectively detect subclinical and clinical therapeutic responses at stages that are earlier than those detected by conventional approaches.
We propose to conduct a prospective study to evaluate therapeutic response using 18F-FDG PET before and after induction chemotherapy for locally advanced NPC patients.
|Study Design:||Primary Purpose: Screening
Time Perspective: Cross-Sectional
Time Perspective: Prospective
|Official Title:||Whole-Body 18F-FDG PET in Evaluating Induction Chemotherapeutic Response for Locally Advanced Nasopharyngeal Cancer Patients and Correlating With Histopathology: a Prospective Study|
|Study Start Date:||March 2006|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00304694
|Contact: Ruoh-Fang Yen, MD, PhD||886-2-23123456 ext email@example.com|
|National Taiwan University Hospital||Recruiting|
|Taipei, Taiwan, 10012|
|Principal Investigator: Ruoh-Fang Yen, MD, PhD|
|Principal Investigator:||Ruoh-Fang Yen, MD, PhD||National Taiwan University Hospital|